CDC Confirms Rising Cases of Drug-Resistant Candida auris Across U.S.

ATLANTA (Day.News) – The CDC reported today a concerning surge in Candida auris (C. auris) infections nationwide. C. auris is a yeast that can cause severe illness, particularly in hospitalized patients or those with weakened immune systems. What distinguishes this fungus is its resistance to many common antifungal medications, making infections difficult to treat. The CDC’s alert highlights a 30% increase in confirmed cases reported in the first quarter of 2026 compared to the same period last year. States hardest hit include New York, California, Illinois, and Florida. Health officials attribute the rise to a combination of factors, including increased testing efforts to identify cases earlier; however, they also acknowledge a genuine increase in transmission within healthcare settings is contributing to the escalation. “We are closely monitoring the situation and working with state and local health departments to implement infection control measures,” said a CDC spokesperson in a released statement. “Early detection and aggressive infection prevention strategies are crucial to containing the spread of C. auris.” These strategies include enhanced hand hygiene among healthcare workers, thorough cleaning and disinfection of hospital rooms, and screening of patients at high risk for colonization. The symptoms of a C. auris infection often mimic those of other infections, which makes diagnosis challenging. Common symptoms include fever, chills, and persistent fatigue. The fungus can invade the bloodstream and other organs, leading to life-threatening complications. Individuals are encouraged to consult a doctor if experiencing these symptoms, especially if they have recently been hospitalized. Of paramount importance is the need to strengthen infection control practices throughout the healthcare system. The CDC encourages hospitals and long-term care facilities to review and update their protocols to prevent the spread of C. auris and other healthcare-associated infections. Increased funding for research into new antifungal treatments is also being advocated by public health organizations. The CDC will hold a press briefing tomorrow outlining further guidance and resources available to healthcare providers and the public. Day.News will provide continuing coverage of this developing health crisis.